Koneksa partners with Beacon to 'revolutionize drug developm

Koneksa partners with Beacon to 'revolutionize drug development'

The digital biomarkers company has partnered with Beacon Biosignlas, a computational neurodiagnostics company to launch a clinical trial investigate the integration of Beacon’s at-home electroencephalogram (EEG) into Koneksa’s neuroscience solution toolkit.

Related Keywords

Jacob Donoghue , Chris Benko , John Wagner , Access Program , Beacon Biosignals , Markets Amp Regulations , Delivery Technologies , Data Management , Digital Biomarker , Alzheimer 039s Disease , Clinical Trials , Atient Centricity , Research ,

© 2025 Vimarsana